Nigeria news

Vaccineswork

How is Nigeria addressing the public health challenges due to COVID-19?

As one of the African countries most affected by COVID-19, Nigeria has faced significant economic and health impacts, including to routine immunisation, in the face of the pandemic.

Nigeria is polio-free. What next?

Throughout the country, all year-round, routine and supplementary immunisation activities took place to ensure that no child was left behind from being vaccinated.

Volunteers take lead on contact tracing in hard-to-reach communities

As COVID-19 has overwhelmed the medical system, a group of volunteers in Nigeria is undertaking the task of slowing the disease’s spread within communities.

Rethinking healthcare in Africa with geospatial mapping

In August 2020, Nigeria became the last African country to be declared free from wild poliovirus.

Preparing ahead: How Imo State harnessed the REDISSE project to improve its COVID-19 response

As at January 12, 2021, Nigeria has had over a hundred thousand confirmed cases of the novel 2019 coronavirus disease (COVID-19) infection. The pandemic has continued to challenge healthcare system...

4 things about mRNA COVID vaccines researchers still want to find out

Researchers are already working to improve the current crop of mRNA vaccines. Hopefully this will help them become more practical and affordable for the entire world, not just first-world countries.

Theme - Pentavalent

Top stories

Canada donates doses through COVAX – Nigeria, Kenya and Niger to receive first doses

Three countries in Africa will receive the first Canadian-donated doses of the AstraZeneca vaccine – Nigeria (801,600 doses), Kenya (459,300) and Niger (100,800) – as part of an overall Canadian pledge of over 40 million doses to COVAX

Nigeria launches major push to protect millions of children against deadliest form of diarrhoeal disease

Today’s launch marks the introduction of the rotavirus vaccine, which protects against rotavirus-related diarrhoeal disease, into Nigeria’s routine immunisation programme.

Gavi launches new learning initiative to address the final barriers to immunisation equity

Reaching the millions of “zero-dose” children who have yet to receive a single vaccine represents one of the final – and most complex – barriers to overcome in the push for global immunisation equity

Funding disbursed to boost vaccine access in humanitarian and fragile settings

The funding will enable international and local civil society organisations to complement public health service efforts by accessing communities not reached by government services, such as in cross-border settings and conflict zones, across the…

Immunisation partners outline ambitious plan to protect millions of girls in lower- and middle-income countries against cervical cancer

Over the next few years, Gavi, the Vaccine Alliance and partners will focus efforts to revitalise access to the human papillomavirus (HPV) vaccine to reach 86 million adolescent girls, rapidly recover and improve coverage, and help build…

Nigeria to vaccinate 7.7 million girls against leading cause of cervical cancer

Nigeria today introduced the human papillomavirus (HPV) vaccine into its routine immunisation system, aiming to reach 7.7 million girls. This is the largest number in a single round of HPV vaccination in the African region in a vaccination drive…

3rd donor pledging featured